UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2

PloS one, 2013-08, Vol.8 (8), p.e73609-e73609

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

International journal of hematology, 2021-03, Vol.113 (3), p.404-412

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma

International journal of hematology, 2021-06, Vol.113 (6), p.797-806

2021

Link zum Volltext

Verfügbarkeit prüfen

Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3

Cancer letters, 2012-06, Vol.319 (1), p.83-88

2012

Link zum Volltext

Verfügbarkeit prüfen

The clonal evolution during long-term clinical course of multiple myeloma

International journal of hematology, 2021-02, Vol.113 (2), p.279-284

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma

International journal of clinical oncology, 2022-01, Vol.27 (1), p.213-223

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

International journal of hematology, 2021-04, Vol.113 (4), p.611-611

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma

Internal Medicine, 2018/04/01, Vol.57(7), pp.939-946

2018

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

Cancer science, 2011-11, Vol.102 (11), p.1949-1957

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

International journal of hematology, 2023-03, Vol.117 (3), p.409-420

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel detection strategy for living circulating tumor cells using 5-aminolevulinic acid

Cancer letters, 2014-12, Vol.355 (1), p.113-120

2014

Link zum Volltext

Verfügbarkeit prüfen

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

International journal of hematology, 2020, Vol.111 (1), p.65-74

2020

Link zum Volltext

Verfügbarkeit prüfen

Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors

Cancer science, 2008-11, Vol.99 (11), p.2200-2208

2008

Link zum Volltext

Verfügbarkeit prüfen

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation

Internal Medicine, 2016/11/01, Vol.55(21), pp.3169-3174

2016

Link zum Volltext

Verfügbarkeit prüfen

Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors

Annals of nuclear medicine, 2017-12, Vol.31 (10), p.719-725

2017

Link zum Volltext

Verfügbarkeit prüfen

Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency

Journal of biochemistry (Tokyo), 2010-07, Vol.148 (1), p.85-92

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study

Japanese journal of clinical oncology, 2018-08, Vol.48 (8), p.736-742

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of ibrutinib in Japanese patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma

Journal of Clinical and Experimental Hematopathology, 2019-12, Vol.59 (4), p.179-186

2019

Link zum Volltext

Verfügbarkeit prüfen

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism

International immunology, 2012-08, Vol.24 (8), p.477-483

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti‐human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells

Cancer science, 2009-11, Vol.100 (11), p.2085-2092

2009

Link zum Volltext

Verfügbarkeit prüfen

Myelomatous meningitis: a case report

International journal of hematology, 2016-08, Vol.104 (2), p.149-150

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma

Clinical cancer research, 2009-04, Vol.15 (7), p.2523-2530

2009

Link zum Volltext

Verfügbarkeit prüfen

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

International journal of oncology, 2015-07, Vol.47 (1), p.97-105

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 315

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(281)

Publikationsform

Artikel
(307)
Berichte
(8)

Sprache

Englisch
(287)
Japanisch
(61)

Erscheinungsjahr

n.n

Thema

Humans
(124)
Science & Technology
(121)
Life Sciences & Biomedicine
(118)
Oncology
(54)
Biological And Medical Sciences
(42)
Hematology
(39)
Male
(38)
Female
(34)
Medical Sciences
(31)
Animals
(26)
Adult
(25)
Mice
(24)
Medicine
(23)
Medicine & Public Health
(23)
Cell Biology
(19)
Cell Line
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Antineoplastic Agents
(14)
Antineoplastic Agents - Therapeutic Use
(14)
General & Internal Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(77)
Journal Of Clinical Oncology
(19)
International Journal Of Hematology
(15)
Cancer Science
(12)
Journal Of Cellular Physiology
(10)
Molecular Cancer Therapeutics
(10)
Breast Cancer
(9)
Gan To Kagaku Ryoho
(9)
Rinsho Ketsueki
(8)
Rinshō Ketsueki
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma

Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3

The clonal evolution during long-term clinical course of multiple myeloma

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma

Correction to: Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma

Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

A novel detection strategy for living circulating tumor cells using 5-aminolevulinic acid

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation

Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors

Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study

Phase I study of ibrutinib in Japanese patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism

Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti‐human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells

Myelomatous meningitis: a case report

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Aktive Filter

Suchergebnisse filtern